Attovia Therapeutics, Inc.
ATTO
IPO
$22.86
-$0.80-3.38%
NASDAQ
| 06/30/2026 | |||||
|---|---|---|---|---|---|
| Revenue | -- | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -- | ||||
| Cost of Revenue | 13.32% | ||||
| Gross Profit | -10.59% | ||||
| SG&A Expenses | 3.05% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 11.52% | ||||
| Operating Income | -9.26% | ||||
| Income Before Tax | -10.89% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | -10.89% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -10.89% | ||||
| EBIT | -9.26% | ||||
| EBITDA | -9.35% | ||||
| EPS Basic | -8.68% | ||||
| Normalized Basic EPS | -8.68% | ||||
| EPS Diluted | -8.68% | ||||
| Normalized Diluted EPS | -8.68% | ||||
| Average Basic Shares Outstanding | 2.03% | ||||
| Average Diluted Shares Outstanding | 2.03% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||